Source disclosure: February 13, 2026
CellSeed Inc. [7776.T]
TOKYO, Feb 13 (Pulse News Wire) – CellSeed Inc. (7776.T) reported non-operating gains and losses for its fiscal year ended December 31, 2025.
The company recorded interest income of ¥2.8 million due to bank deposits. However, it also incurred interest expenses of ¥1.9 million related to bank borrowings and issuance costs of ¥6.3 million associated with the exercise of the 25th tranche of warrant rights. Additionally, foreign exchange losses of ¥616,000 were recognized due to recent fluctuations in exchange rates.
Regarding extraordinary items, the company wrote off stock options granted to employees, resulting in a gain of ¥2.7 million from the extinguishment of warrants upon expiration of the 15th tranche's exercise period. Conversely, impairment losses of ¥52.7 million were recognized on tangible fixed assets due to signs of impairment. These figures are reflected in the company’s unaudited consolidated earnings release for the fiscal year ending December 31, 2025, published today.
AI-translated content. 🟢 Confidence: High See terms • Original filing